Literature DB >> 9317057

Cyclosporin for severe ulcerative colitis: a user's guide.

A Kornbluth1, D H Present, S Lichtiger, S Hanauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317057

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  24 in total

1.  Management of difficult inflammatory bowel disease: where are we now?

Authors:  DS Rampton
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Ulcerative colitis: current treatment strategies and future prospects.

Authors:  Sagar Garud; Mark A Peppercorn
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

Review 3.  New targets for mucosal healing and therapy in inflammatory bowel diseases.

Authors:  M F Neurath
Journal:  Mucosal Immunol       Date:  2013-10-02       Impact factor: 7.313

4.  The Role of Cyclosporine Therapy in Ulcerative Colitis Treatment.

Authors:  Simon Lichtiger
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

5.  Immunomodulator Therapy in Inflammatory Bowel Disease.

Authors:  Peter E. Legnani; Asher Kornbluth
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

6.  Molecular mechanism of interleukin-2-induced mucosal homeostasis.

Authors:  Jayshree Mishra; Christopher M Waters; Narendra Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-23       Impact factor: 4.249

Review 7.  Management of inflammatory bowel disease.

Authors:  M Nayar; J M Rhodes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

8.  Medical treatment of ulcerative colitis.

Authors:  Uma Mahadevan
Journal:  Clin Colon Rectal Surg       Date:  2004-02

Review 9.  Treatment of inflammatory bowel disease: a review of medical therapy.

Authors:  Patricia L Kozuch; Stephen B Hanauer
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

10.  Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis.

Authors:  Takeshi Tomomasa; Akio Kobayashi; Hiroaki Kaneko; Sasaki Mika; Shun-Ichi Maisawa; Yoshie Chino; Hohkibara Syou; Atsushi Yoden; Jyunko Fujino; Makoto Tanikawa; Takafumi Yamashita; Shigeru Kimura; Maiko Kanoh; Koji Sawada; Akihiro Morikawa
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.